{
  "id": "deab889f1f814adf",
  "title": "Novo CEO Sees Strong Demand for Wegovy Obesity Pill",
  "description": "Novo Nordisk CEO Mike Doustdar talks about launching a pill version of their blockbuster obesity drug Wegovy in the US. He speaks to Katie Greifeld in San Francisco at the annual JPMorgan Healthcare Conference.\u00a0 (Source: Bloomberg)",
  "content": "Novo Nordisk CEO Mike Doustdar talks about launching a pill version of their blockbuster obesity drug Wegovy in the US. He speaks to Katie Greifeld in San Francisco at the annual JPMorgan Healthcare Conference.\u00a0 (Source: Bloomberg)",
  "source": "Bloomberg Markets",
  "source_url": "https://www.bloomberg.com/news/videos/2026-01-13/novo-ceo-sees-strong-demand-for-wegovy-obesity-pill-video",
  "published_at": "2026-01-13T21:10:09+00:00",
  "fetched_at": "2026-01-14T00:24:05.619157+00:00",
  "category": "macroeconomics_finance",
  "subcategory": null,
  "keywords": [
    "healthcare",
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "Novo CEO Sees Strong Demand for Wegovy Obesity Pill",
    "description": "Novo Nordisk CEO Mike Doustdar talks about launching a pill version of their blockbuster obesity drug Wegovy in the US. He speaks to Katie Greifeld in San Francisco at the annual JPMorgan Healthcare Conference.\u00a0 (Source: Bloomberg)",
    "url": "https://www.bloomberg.com/news/videos/2026-01-13/novo-ceo-sees-strong-demand-for-wegovy-obesity-pill-video",
    "published": "2026-01-13T21:10:09+00:00",
    "source": "Bloomberg Markets"
  }
}